Genetic evidence for role of carotenoids in age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS).

scientific article published on 29 January 2014

Genetic evidence for role of carotenoids in age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS). is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1167/IOVS.13-13216
P932PMC publication ID3908680
P698PubMed publication ID24346170
P5875ResearchGate publication ID259352377

P50authorRobert P IgoQ92784819
Kristin N MeyerQ96127926
Gloria E SartoQ114375000
Barbara J TruittQ114447141
Chitra K KarkiQ114723333
Karen M GehrsQ58411078
Sudha IyengarQ64008607
Lesley F TinkerQ85643662
Paul S BernsteinQ88167571
Erin S LeBlancQ89239956
Amy E MillenQ90397187
P2093author name stringMichael Klein
Zhe Liu
Elizabeth J Johnson
Corinne D Engelman
Robert Wallace
John Paul SanGiovanni
Julie A Mares
Barbara Blodi
Jennifer Robinson
P2860cites workPopulation structure and eigenanalysisQ21145248
A mitochondrial enzyme degrades carotenoids and protects against oxidative stressQ24308718
Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degenerationQ24622351
Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC)Q24622766
PLINK: a tool set for whole-genome association and population-based linkage analysesQ24677407
Genetic variants in BCMO1 and CD36 are associated with plasma lutein concentrations and macular pigment optical density in humans.Q51386596
Apolipoprotein E Gene Associations in Age-related Macular Degeneration: The Melbourne Collaborative Cohort StudyQ57100196
Dietary lutein, zeaxanthin, and fats and the progression of age-related macular degenerationQ57254341
Associations Between Intermediate Age-Related Macular Degeneration and Lutein and Zeaxanthin in the Carotenoids in Age-Related Eye Disease Study (CAREDS)Q63344335
Reducing the Genetic Risk of Age-Related Macular Degeneration With Dietary Antioxidants, Zinc, and ω-3 Fatty AcidsQ64461561
Preliminary identification of the human macular pigmentQ69790666
Human plasma carotenoid response to the ingestion of controlled diets high in fruits and vegetablesQ71611064
Distributions of carotenoids and alpha-tocopherol among lipoproteins do not change when human plasma is incubated in vitroQ71749317
Effects of supplemental beta-carotene, cigarette smoking, and alcohol consumption on serum carotenoids in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention StudyQ73570510
Dietary modification of human macular pigment densityQ73671816
Ultrastructural changes in Bruch's membrane of apolipoprotein E-deficient miceQ73990815
Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye StudyQ74805233
Effects of fish oil fatty acids on plasma lipids and lipoproteins and oxidant-antioxidant imbalance in healthy subjectsQ78175112
Predictors of optical density of lutein and zeaxanthin in retinas of older women in the Carotenoids in Age-Related Eye Disease Study, an ancillary study of the Women's Health InitiativeQ79340995
The prime role of HDL to transport lutein into the retina: evidence from HDL-deficient WHAM chicks having a mutant ABCA1 transporterQ80853945
The influence of supplemental lutein and docosahexaenoic acid on serum, lipoproteins, and macular pigmentationQ81247711
CMO1 deficiency abolishes vitamin A production from beta-carotene and alters lipid metabolism in miceQ81250317
The ABCG5 polymorphism contributes to individual responses to dietary cholesterol and carotenoids in eggsQ83154450
Evaluation of serum lipid concentrations and genetic variants at high-density lipoprotein metabolism loci and TIMP3 in age-related macular degenerationQ84196756
Lutein supplementation reduces plasma lipid peroxidation and C-reactive protein in healthy nonsmokersQ86093278
Principal components analysis corrects for stratification in genome-wide association studiesQ27860975
An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degenerationQ28190470
The Relationship of Dietary Carotenoid and Vitamin A, E, and C Intake With Age-Related Macular Degeneration in a Case-Control StudyQ28248143
Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular DegenerationQ28290149
Carotenoids in the human macula and whole retinaQ28609504
Seven new loci associated with age-related macular degenerationQ29416998
Quality control and quality assurance in genotypic data for genome-wide association studiesQ30498925
Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patientsQ30858951
Influence of lutein supplementation on macular pigment, assessed with two objective techniques.Q30929610
Association of HDL-related loci with age-related macular degeneration and plasma lutein and zeaxanthin: the Alienor studyQ31143690
Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment densityQ31389893
Macular pigment and risk for age-related macular degeneration in subjects from a Northern European populationQ31830839
Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye.Q31951685
Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination surveyQ32066253
Macular pigment lutein is antiinflammatory in preventing choroidal neovascularizationQ33302396
Discerning the ancestry of European Americans in genetic association studiesQ33315561
rs5888 variant of SCARB1 gene is a possible susceptibility factor for age-related macular degenerationQ33508828
A nonsense mutation in the beta-carotene oxygenase 2 (BCO2) gene is tightly associated with accumulation of carotenoids in adipose tissue in sheep (Ovis aries).Q33528280
The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23Q33613367
Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degenerationQ33634096
Genome-wide association study identifies variants at the IL18-BCO2 locus associated with interleukin-18 levelsQ33740363
Nutritional manipulation of primate retinas, V: effects of lutein, zeaxanthin, and n-3 fatty acids on retinal sensitivity to blue-light-induced damageQ33796324
A genetic risk score combining ten psoriasis risk loci improves disease predictionQ33894914
Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndromeQ33953350
The role of oxidative stress in the pathogenesis of age-related macular degeneration.Q34060719
Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory studyQ34108927
Association of macular pigment density with plasma ω-3 fatty acids: the PIMAVOSA studyQ34138412
Long-chain and very long-chain polyunsaturated fatty acids in ocular aging and age-related macular degenerationQ34188018
Macular carotenoid supplementation in subjects with atypical spatial profiles of macular pigment.Q34278325
Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study GroupQ34323879
Distribution of lutein and zeaxanthin stereoisomers in the human retinaQ34428109
n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseasesQ34569101
Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthinQ34627818
Single nucleotide polymorphisms upstream from the β-carotene 15,15'-monoxygenase gene influence provitamin A conversion efficiency in female volunteersQ34633920
A2E and blue light in the retina: the paradigm of age-related macular degenerationQ34658953
Prediction of individual genetic risk to disease from genome-wide association studiesQ34676890
The effect of lutein supplementation on blood plasma levels of complement factor D, C5a and C3d.Q34979785
Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteinsQ35056603
Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studiesQ35552553
Evaluation of new and established age-related macular degeneration susceptibility genes in the Women's Health Initiative Sight Exam (WHI-SE) StudyQ35658968
The heritability of macular response to supplemental lutein and zeaxanthin: a classic twin studyQ36136223
The inflammation highway: metabolism accelerates inflammatory traffic in obesityQ36174974
The putative role of lutein and zeaxanthin as protective agents against age-related macular degeneration: promise of molecular genetics for guiding mechanistic and translational research in the field.Q36317120
Carotenoid actions and their relation to health and diseaseQ36323052
The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1)Q36360812
Xanthophylls are preferentially taken up compared with beta-carotene by retinal cells via a SRBI-dependent mechanismQ36745022
Genetic determinants of macular pigments in women of the Carotenoids in Age-Related Eye Disease StudyQ36766616
Prospective study of lutein/zeaxanthin intake and risk of age-related macular degenerationQ36825090
Single nucleotide polymorphisms in CETP, SLC46A1, SLC19A1, CD36, BCMO1, APOA5, and ABCA1 are significant predictors of plasma HDL in healthy adultsQ36843378
Delta6-desaturase (FADS2) deficiency unveils the role of omega3- and omega6-polyunsaturated fatty acidsQ36862651
Macular pigment and lutein supplementation in ABCA4-associated retinal degenerationsQ37069102
Lutein and zeaxanthin supplementation reduces photooxidative damage and modulates the expression of inflammation-related genes in retinal pigment epithelial cellsQ37098578
Dietary omega-3 fatty acids, other fat intake, genetic susceptibility, and progression to incident geographic atrophyQ37134473
Common variation in the beta-carotene 15,15'-monooxygenase 1 gene affects circulating levels of carotenoids: a genome-wide association studyQ37156081
Genetic ablation of carotene oxygenases and consumption of lycopene or tomato powder diets modulate carotenoid and lipid metabolism in miceQ37246324
New roles of HDL in inflammation and hematopoiesisQ37314961
Two carotenoid oxygenases contribute to mammalian provitamin A metabolismQ37333819
Investigation of genetic variation in scavenger receptor class B, member 1 (SCARB1) and association with serum carotenoidsQ37625442
Prediction of age-related macular degeneration in the general population: the Three Continent AMD ConsortiumQ37702757
Colors with functions: elucidating the biochemical and molecular basis of carotenoid metabolismQ37736472
Marked HDL deficiency and premature coronary heart disease.Q37771219
Proteins involved in uptake, intracellular transport and basolateral secretion of fat-soluble vitamins and carotenoids by mammalian enterocytesQ37901804
Genetic variations involved in interindividual variability in carotenoid status.Q37940438
Importance of β,β-carotene 15,15'-monooxygenase 1 (BCMO1) and β,β-carotene 9',10'-dioxygenase 2 (BCDO2) in nutrition and healthQ37965458
Sunlight exposure, antioxidants, and age-related macular degenerationQ39006183
Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degenerationQ39575237
Purification and partial characterization of a lutein-binding protein from human retinaQ42025555
Lutein transport by Caco-2 TC-7 cells occurs partly by a facilitated process involving the scavenger receptor class B type I (SR-BI).Q42470830
Patients with Sjögren-Larsson syndrome lack macular pigment.Q43158883
Apolipoprotein E genotype is associated with macular pigment optical densityQ43182517
Genetic variation in the beta, beta-carotene-9', 10'-dioxygenase gene and association with fat colour in bovine adipose tissue and milkQ43227945
Macular pigment in donor eyes with and without AMD: a case-control study.Q43514008
The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6.Q43796210
Neovascular age-related macular degeneration and its relationship to antioxidant intakeQ44110946
Identification and functional analysis of a naturally occurring E89K mutation in the ABCA1 gene of the WHAM chicken.Q44168282
Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA studyQ44212321
Neuroprotective effect of an antioxidant, lutein, during retinal inflammationQ44386863
Lutein and zeaxanthin status and risk of age-related macular degeneration.Q44453108
Effects of omega-3 fatty acid supplementation and exercise on low-density lipoprotein and high-density lipoprotein subfractionsQ44911463
Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot studyQ44925974
Nutritional manipulation of primate retinas, II: effects of age, n-3 fatty acids, lutein, and zeaxanthin on retinal pigment epitheliumQ45028017
Identification and characterization of a Pi isoform of glutathione S-transferase (GSTP1) as a zeaxanthin-binding protein in the macula of the human eye.Q45050501
Morphologic and electroretinographic phenotype of SR-BI knockout mice after a long-term atherogenic diet.Q46023211
The effect of dietary docosahexaenoic acid on plasma lipoproteins and tissue fatty acid composition in humansQ46175085
Carotenoid transport is decreased and expression of the lipid transporters SR-BI, NPC1L1, and ABCA1 is downregulated in Caco-2 cells treated with ezetimibeQ46715258
Heritability of macular pigment: a twin studyQ46816863
Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973.Q50268024
Xanthophyll accumulation in the human retina during supplementation with lutein or zeaxanthin - the LUXEA (LUtein Xanthophyll Eye Accumulation) study.Q50474439
Supplementation with the carotenoids lutein or zeaxanthin improves human visual performance.Q50478568
Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans.Q50495142
Involvement of cholesterol membrane transporter Niemann-Pick C1-like 1 in the intestinal absorption of lutein.Q50497118
P433issue1
P407language of work or nameEnglishQ1860
P921main subjecteye diseaseQ3041498
macular degenerationQ27429789
P304page(s)587-599
P577publication date2014-01-29
P1433published inInvestigative Ophthalmology Visual ScienceQ6060707
P1476titleGenetic evidence for role of carotenoids in age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS).
P478volume55

Reverse relations

cites work (P2860)
Q28512836A genetic dissection of intestinal fat-soluble vitamin and carotenoid absorption
Q26823002Age-related Eye Disease Study 2: perspectives, recommendations, and unanswered questions
Q26801165Asparaginase treatment side-effects may be due to genes with homopolymeric Asn codons (Review-Hypothesis)
Q92188405Associations Between the Apolipoprotein E ε4 Allele and Reduced Serum Levels of High Density Lipoprotein a Cognitively Normal Aging Han Chinese Population
Q34185581Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study
Q37686531Brain xanthophyll content and exploratory gene expression analysis: subspecies differences in rhesus macaque
Q28551885Circulating Autoantibodies in Age-Related Macular Degeneration Recognize Human Macular Tissue Antigens Implicated in Autophagy, Immunomodulation, and Protection from Oxidative Stress and Apoptosis
Q45072284Context-dependent compensation among phosphatidylserine-recognition receptors
Q47106416Dietary guidance for lutein: consideration for intake recommendations is scientifically supported
Q61447542Exploring the differential mechanisms of carotenoid biosynthesis in the yellow peel and red flesh of papaya
Q49597781Genetic Loci Controlling Carotenoid Biosynthesis in Diverse Tropical Maize Lines.
Q39094660Host-related factors explaining interindividual variability of carotenoid bioavailability and tissue concentrations in humans
Q39533399Increased Macular Pigment Optical Density and Visual Acuity following Consumption of a Buttermilk Drink Containing Lutein-Enriched Egg Yolks: A Randomized, Double-Blind, Placebo-Controlled Trial
Q30829406Intakes of Lutein, Zeaxanthin, and Other Carotenoids and Age-Related Macular Degeneration During 2 Decades of Prospective Follow-up
Q57177518Intrinsic and Extrinsic Factors Impacting Absorption, Metabolism, and Health Effects of Dietary Carotenoids
Q92269896Investigating the potential of Zernike polynomials to characterise spatial distribution of macular pigment
Q46443587Lack of β, β-carotene-9', 10'-oxygenase 2 leads to hepatic mitochondrial dysfunction and cellular oxidative stress in mice
Q40703905Light, lipids and photoreceptor survival: live or let die?
Q91617441Limited appearance of apocarotenoids is observed in plasma after consumption of tomato juices: a randomized human clinical trial
Q38901504Lutein and Zeaxanthin Isomers in Eye Health and Disease
Q30693939Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease
Q38751193Mechanisms of selective delivery of xanthophylls to retinal pigment epithelial cells by human lipoproteins
Q89607086Mechanistic understanding of β-cryptoxanthin and lycopene in cancer prevention in animal models
Q37347216Molecular aspects of β, β-carotene-9', 10'-oxygenase 2 in carotenoid metabolism and diseases
Q37592954Nutritional and Lifestyle Interventions for Age-Related Macular Degeneration: A Review
Q38317289Nutritional supplements in age-related macular degeneration
Q38921719Plasma long-chain omega-3 polyunsaturated fatty acids and macular pigment in subjects with family history of age-related macular degeneration: the Limpia Study
Q37715993Potential protective function of the sterol regulatory element binding factor 1-fatty acid desaturase 1/2 axis in early-stage age-related macular degeneration
Q35819298Restoration of mesenchymal retinal pigmented epithelial cells by TGFβ pathway inhibitors: implications for age-related macular degeneration
Q49897721Rethinking Phagocytes: Clues from the Retina and Testes.
Q91756849Review on nutritional composition of orange-fleshed sweet potato and its role in management of vitamin A deficiency
Q38828895Risk factors and biomarkers of age-related macular degeneration
Q91883858Single Nucleotide Polymorphisms in β-Carotene Oxygenase 1 are Associated with Plasma Lycopene Responses to a Tomato-Soy Juice Intervention in Men with Prostate Cancer
Q36586130Synthesis of docosahexaenoic acid from eicosapentaenoic acid in retina neurons protects photoreceptors from oxidative stress
Q47130133Targeted Metabolomics Reveals Abnormal Hepatic Energy Metabolism by Depletion of β-Carotene Oxygenase 2 in Mice
Q58611705The Role of Diet, Micronutrients and the Gut Microbiota in Age-Related Macular Degeneration: New Perspectives from the Gut⁻Retina Axis
Q35106624The relationship between BCMO1 gene variants and macular pigment optical density in persons with and without age-related macular degeneration
Q59446743What do we know about the macular pigment in AMD: the past, the present, and the future

Search more.